View : 633 Download: 0
Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
- Title
- Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
- Authors
- Uhm J.-S.; Kim J.; Yu H.T.; Kim T.-H.; Lee S.-R.; Cha M.-J.; Choi E.-K.; Lee J.M.; Kim J.-B.; Park J.; Park J.-K.; Kang K.-W.; Shim J.; Park H.W.; Lee Y.S.; Kim C.-S.; Mun J.E.; Son N.-H.; Joung B.
- Ewha Authors
- 박준범
- SCOPUS Author ID
- 박준범
- Issue Date
- 2021
- Journal Title
- ESC Heart Failure
- ISSN
- 2055-5822
- Citation
- ESC Heart Failure vol. 8, no. 2, pp. 1582 - 1589
- Keywords
- Atrial fibrillation; Bleeding; Ejection fraction; Heart failure; Stroke; Systemic embolism
- Publisher
- John Wiley and Sons Inc
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Aims: This study aimed to elucidate the risk for stroke and systemic embolism (SE) in patients with atrial fibrillation and heart failure (HF) according to HF type. Methods and results: A total of 10 780 patients with atrial fibrillation were enrolled in a multicentre prospective registry and divided according to HF type: no-HF, HF with preserved ejection fraction (EF) (HFpEF), HF with mid-range EF (HFmrEF), and HF with reduced EF (HFrEF). Each group included 237 age-matched and sex-matched patients (age, 69.0 ± 10.3 years; men, 69.6%). The baseline characteristics, cumulative incidence, and hazard ratios for stroke/SE and major bleeding were compared across the groups. Patients with HF accounted for 10.3% of the total population; HFpEF, HFmrEF, and HFrEF represented 43.7%, 23.6%, and 32.7% of the patients with HF, respectively. The CHA2DS2-VASc score was significantly higher in the HFpEF, HFmrEF, and HFrEF groups than in the no-HF group. The annual stroke/SE incidence rates were 2.8%, 0.7%, 1.1%, and 0.9% in the HFpEF, HFmrEF, HFrEF, and no-HF groups, respectively. The cumulative incidence of stroke/SE was significantly highest in the HFpEF group at 22.8 ± 10.0 months (P = 0.020). The stroke/SE risk was higher in the HFpEF group than in the HFmrEF and HFrEF groups (hazard ratio, 3.192; 95% confidence interval, 1.039–9.810; P = 0.043). E/e' value was an independent risk factor for stroke/SE. There were no significant differences in the incidence of major bleeding across the groups. Conclusions: The stroke/SE risk was the highest in the HFpEF group and comparable between the HFmrEF and HFrEF groups. © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
- DOI
- 10.1002/ehf2.13264
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML